My SciELO
Services on Demand
Journal
Article
Indicators
- Cited by SciELO
- Access statistics
Related links
- Cited by Google
- Similars in SciELO
- Similars in Google
Share
Sanidad Militar
Print version ISSN 1887-8571
Abstract
APARICIO HERNANDEZ, R; GARCIA LUQUE, A; PRATS OLIVAN, P and SANCHEZ LOPEZ, P. Possitive assesment of drugs: September, October and November 2018. Sanid. Mil. [online]. 2019, vol.75, n.1, pp.19-26. ISSN 1887-8571. https://dx.doi.org/10.4321/s1887-85712019000100004.
The drugs assessed by the Spanish Agency for Medicines and Health Products or European Medicines Agency made public in September, October and November of 2018, and considered of interest to the healthcare profesional, are reviewed. These are positive technical reports prior to the authorization and placing on the market of the product.
Keywords : Antígenos de superficie inactivados del virus de la gripe, hemaglutinina y neuraminidasa (Flucelvax tetra®); Apalutamida (Erleada®); Brigatinib (Alunbrig®); Damoctocog alfa pegol (Jivi®); Doravirina (Pifeltro®); Doravirina, Lamivudina, Tenofovir disoproxilo (Delstrigo®); Galcanezumab (Emgality®); Glicopirronio/Formoterol fumarato dihidrato (Bevespi aerosphere®); Macimorelina (Macimorelin aeterna zentaris®); Meropenem/Vaborbactam (Vabomere®); Ladanelumab (Takhzyro®); Mexiletina (Namuscla®); Mogamulizumab (Poteligeo®); Paclitaxel (Apealea®); Pegfilgrastim (Fulphila®; Pelmeg®; Ziextenzo®); Trastuzumab (Ogivri®); Vacuna viva atenuada tetravalente del dengue (Dengvaxia®); Voretigene neparvovec (Luxturna®).